Mind the Byte and Prosilico sign a strategic partnership agreement Blog Post

Mind the Byte, located at the Barcelona Science Park (PCB) and at Copenhagen BioScience Park (COBIS), announces that it has just signed an agreement to share technology with the Swedish-based company Prosilico. This agreement fits with the Catalan bioinformatics company’s plans to expand internationally through strategic alliances and increase its range of services.

 

Bioengineering for Healthy Ageing Blog Post

Under the theme of “Bioengineering for Healthy Ageing. Adding Life to Years”, more than 75 international scientists, clinicians and other experts met yesterday at CosmoCaixa Barcelona in an event hosted by B·Debate, an initiative of Biocat and the “la Caixa” Foundation. In this edition, the Institute for Bioengineering of Catalonia (IBEC) –based at the Barcelona Science Park– led the event that brougth together world-renowned researchers to examine possible solutions bioengineering can provide to address the challenges an ageing population faces.

 

Entities from PCB promote their international presence at BIO-Europe 2017 Blog Post

From 6 to 8 November, Belin will host BIO-Europe 2017, the largest partnering gathering of the biotech and pharmaceutical industry in Europe and one of the largest in the world. The event, organized by EBD-Group with the collaboration of Biocat –based at the Barcelona Science Park (PCB)– will again draw over 3,800 industry attendees from over 60 countries, representing more than 2,000 companies and It will have a important representation of PCB.

 

Esteve closes the Board of Directors renewal process with the appointment of Joan Esteve as a Chairman Blog Post

Esteve has just announced changes to its corporate governing bodies. In line with the plan approved by the Group’s Board, Albert Esteve will replace Joan Esteve as Chairman of the Board and announces the appointment of Staffan Schüberg, executive vicepresident of the Danish pharmaceutical company Lundbeckas, the group’s Chief Executive Officer. Since 2012, all discovery and preclinical development key units of Esteve are located at the Barcelona Science Park with the latest infrastructure and technology in a top-level academic and scientific environment in Spain.

 

IBEC researchers show that physical forces activate genes involved in cancer Blog Post

IBEC’s researchers at PCB, led by Pere Roca-Cusachs, reveal how forces trigger the expression of certain genes by increasing the activity of a protein called YAP in the nucleus of the cell.  The results of the study, published in Cell, have shown how these forces ‘switch on’ the expression of genes that may result in cancer.

 

Embryotools successfully concludes the first trials on an innovative assisted reproduction technique Blog Post

Embryotools —headquartered at Barcelona Science Park (PCB)— has successfully concluded tests on animal models to validate an innovative assisted reproduction technique known as Maternal Spindle Transfer (MST).  This new technique is a mitochondrial replacement therapy which groups of leading scientists from around the world are studying for the prevention of mitochondrial diseases, which are transmitted maternally and currently have no treatment. Embryotools has been working on this project for over three years in partnership with the PCB-PRBB Animal Facility Alliance and the company Reprogenetics UK, located at Oxford University.

 

An increase in low density lipoproteins would favour insulin resistance Blog Post

A study led by the University of Barcelona proved that low-density proteins (VLDL) can worsen insulin resistance, a disease that favours the development of type 2 diabetes. The study, published in the scientific journal Diabetologia , has been carried out by the research group led by Manuel Vázquez Carrera, researcher from the Department of Pharmacology, Toxicology and Therapeutic Chemistry and the Institute of Biomedicine of the UB (IBUB), located at the Barcelona Science Park.